<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00914030</url>
  </required_header>
  <id_info>
    <org_study_id>2008-A01459-46</org_study_id>
    <nct_id>NCT00914030</nct_id>
  </id_info>
  <brief_title>Visual Exploration and Attention: Studies in Patients With Schizophrenia and Autism Spectrum Disorders</brief_title>
  <official_title>Visual Exploration and Attention : Studies in Patients With Schizophrenia and Autism Spectrum Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the protocol is to better understand the impairments in visual processing, as such
      impairments may induce social interaction difficulties in subjects with autism spectrum
      disorders (adults and children) and schizophrenia, like face exploration.The same protocol
      will be used for the three populations, each population being compared with matched controls.
      The explorations are designed to test two different hypotheses regarding the mechanisms of
      the visual perception difficulties of the two populations. Even though difficulties to
      extract the global form of objects have been described in both subjects with autism and
      schizophrenia, we will test two different hypotheses for the two populations. We will test
      the hypothesis that subjects with autism display an advantage for the processing of local
      information arising at an early level of processing, whereas disorders observed in patients
      with schizophrenia originate from attention disorders. The protocol includes three
      consecutive studies, each one being applied in each of the three populations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Autism Spectrum Disorders</condition>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>A1</arm_group_label>
    <description>Patients with schizophrenia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A2</arm_group_label>
    <description>Control subjects matched individually with patients with schizophrenia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B1</arm_group_label>
    <description>Adult subjects with autism</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B2</arm_group_label>
    <description>Control subjects matched individually with adult subjects with autism</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C1</arm_group_label>
    <description>Children with autism</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C2</arm_group_label>
    <description>Control subjects matched individually with children with autism</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neuropsychological evaluation</intervention_name>
    <description>Study one: global/local processing, with a neutral prime (stimulus influencing the processing of the subsequent stimulus)Study two: global/ local processing with a prime whose elements are collinear.Study three: global/local processing with a prime whose elements are not collinear</description>
    <arm_group_label>A1</arm_group_label>
    <arm_group_label>A2</arm_group_label>
    <arm_group_label>B1</arm_group_label>
    <arm_group_label>B2</arm_group_label>
    <arm_group_label>C1</arm_group_label>
    <arm_group_label>C2</arm_group_label>
    <other_name>Each study will be conducted successively in each group (A1/ A2, B1/B2, C1/C2).</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Psychiatry clinic in Strasbourg and Brumath. Pedopsychiatry Clinic in Strasbourg. Residents
        of Strasbourg and Brumath
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  IQ above 70, as evaluated with the WAIS III in adults and with the WISC in children

          -  signed consent

          -  DSM IV criteria in case of autism spectrum disorders or schizophrenia

        Exclusion Criteria:

          -  grave or non stabilized somatic pathology

          -  pathology affecting the central nervous system; other than the studied pathologies

          -  intake of psychotropic drug, except for patients

          -  invalidating sensory processes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne GIERSCH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>GIERSCH Anne, MD</last_name>
    <email>giersch@unistra.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pôle départemental du Centre de Ressources Autisme pour adultes (67) - Etablissement public de santé Alsace-Nord (site de Brumath)</name>
      <address>
        <city>Brumath</city>
        <zip>67170</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>HOCHNER Arielle, MD</last_name>
      <email>arielle.hochner@ch-epsan.fr</email>
    </contact>
    <investigator>
      <last_name>HOCHNER Arielle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>WEINER Luisa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de Ressources Autisme Pôle adultes (68) - Espace Autisme 68</name>
      <address>
        <city>Colmar</city>
        <zip>68000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MURAD Ayman, MD</last_name>
      <email>murad@ch-rouffach.fr</email>
    </contact>
    <investigator>
      <last_name>MURAD Ayman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Lautréamont</name>
      <address>
        <city>Loos</city>
        <zip>59120</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GONIN Olivier, MD</last_name>
      <email>Olivier.gonin4@wanadoo.fr</email>
    </contact>
    <investigator>
      <last_name>GONIN Olivier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pôle régional du Centre de Ressources Autisme pour enfants et adolescents - Unité d'évaluation des troubles du développement Hôpital de l'Elsau - Pôle de Psychiatrie - Unité d'évaluation des troubles du développement Hôpital de l'Elsau - HUS</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GRAS-VINCENDON Agnès, MD</last_name>
      <email>agnes.gras@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>GRAS-VINCENDON Agnès, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>CHABAUX-DELARAI Catherine, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>INSERM U666 ; Pôle de Psychiatrie - Service de Psychiatrie Adulte- HUS</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GIERSCH Anne, MD</last_name>
      <email>giersch@unistra.fr</email>
    </contact>
    <investigator>
      <last_name>GIERSCH Anne, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2009</study_first_submitted>
  <study_first_submitted_qc>June 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2009</study_first_posted>
  <last_update_submitted>August 25, 2016</last_update_submitted>
  <last_update_submitted_qc>August 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Visual perception</keyword>
  <keyword>Local/global processing</keyword>
  <keyword>Attention</keyword>
  <keyword>Visual priming</keyword>
  <keyword>Collinearity</keyword>
  <keyword>Grouping</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

